Search Results 551-560 of 18343 for Lactation

1. A Study Comparing Recombinant Von Willebrand Factor (rVWF) vs. Tranexamic Acid (TA) to Minimize Menorrhagia in Women with Type 1 Von Willebrand Disease - Mayo Clinic

   Participation eligibility · Any bleeding disorder other than von Willebrand disease; or past thrombotic disease · Pregnant or lactating, or use of hormones or ...

2. Preterm labor - Symptoms and causes - Mayo Clinic

   Preterm labor happens when regular contractions cause the cervix to open after week 20 and before week 37 of pregnancy. Preterm labor can result in a baby being ...

3. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

   Males or non-pregnant, non-lactating females, ages 18 to 75 years, inclusive based on the date of the screening visit; Documented diagnosis of UC of at least ...

4. Stages of labor and birth: Baby, it's time! - Mayo Clinic

   Try breathing or relaxation techniques taught in childbirth class. Change positions. If your pregnancy isn't high risk, you may spend most of your early labor ...

5. Cellular Immunotherapy Treatment Antigen-Directed for EBV Lymphoma - Mayo Clinic

   Patient is pregnant or lactating. Female patient of childbearing potential unwilling to use effective birth control. Sexually active patients unwilling to ...

6. Brentuximab Vedotin and Combination Chemotherapy in Treating Younger Patients with Newly Diagnosed Hodgkin Lymphoma - Mayo Clinic

   Lactating females who plan to breastfeed; Sexually active patients of reproductive potential who have not agreed to use an effective contraceptive method for ...

7. Study of Dexamethasone Plus IXAZOMIB or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis - Mayo Clinic

   Female patients who are lactating, breastfeeding or pregnant; Evidence of current uncontrolled cardiovascular conditions as specified in study protocol ...

8. https://www.mayoclinic.org/spanish_organization_concepts.xml

9. Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR - Mayo Clinic

   * For women of child-bearing potential: pregnant or lactating or intending to become pregnant within the next 3 years. * Women of childbearing potential ...

10. A Study to Assess the Effectiveness and Safety of Ublituximab in combination with Umbralisib and Venetoclax (U2-V) Compared to Ublituximab and Umbralisib (U2) in Subjects with Chronic Lymphocytic Leukemia (CLL) - Mayo Clinic

    Women who are pregnant or lactating. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the most up-to-date ...